Literature DB >> 28774371

[Effect of baicalin on behavioral characteristics of rats with attention deficit hyperactivity disorder].

Rong-Yi Zhou1, Xin-Min Han, Jiao-Jiao Wang, Hai-Xia Yuan, Ji-Chao Sun, Yue You, Yu-Chen Song.   

Abstract

OBJECTIVE: To investigate the effect of baicalin on the behavioral characteristics of rats with attention deficit hyperactivity disorder (ADHD), and to provide a basis for further research on baicalin in the treatment of ADHD.
METHODS: A total of 40 SHR rats were randomly divided into model group, methylphenidate hydrochloride (MPH) group, and low-, medium-, and high-dose baicalin groups, with 8 rats in each group. Eight WKY rats were selected as normal control group. The rats in the MPH group (0.07 mg/mL) and the low- (3.33 mg/mL), medium- (6.67 mg/mL), and high-dose (10 mg/mL) baicalin groups were given the corresponding drugs (1.5 mL/100 g) by gavage twice a day, and those in the normal control group and the model group were given an equal volume of normal saline by gavage twice a day. The course of treatment was 4 weeks for all groups. The open field test was performed to observe total moving distance and average moving speed on day 0 of experiment and at 7, 14, 21, and 28 days after gavage and to evaluate the control effects of drugs on hyperactivity and impulsive behavior. The Morris water maze test was used to observe the latency, time spent in the target quadrant, and number of platform crossings and to evaluate the effects of drugs on attention.
RESULTS: The open field test showed that the model group and the drug treatment groups had a significantly longer total moving distance and a significantly higher average moving speed than the normal control group on day 0 (P<0.05). On day 7, the MPH group had significant reductions in total moving distance and average moving speed compared with the model group (P<0.05). On day 14, the MPH group and the high-dose baicalin group had significant reductions in total moving distance and average moving speed compared with the model group (P<0.05). The data on days 21 and 28 showed that compared with the model group, the low-, medium-, and high-dose baicalin groups had gradual reductions in total moving distance and average moving speed (P<0.05). The water maze test showed that compared with the model group, the MPH group and the medium- and high-dose baicalin groups had a significantly longer time spent in the target quadrant (P<0.05), and the MPH group and the high-dose baicalin group had a significantly higher proportion of the moving distance in the target quadrant in total moving distance (P<0.05). The high-dose baicalin group had the highest number of platform crossings among all groups (P<0.05).
CONCLUSIONS: Both baicalin and MPH can regulate the motor ability and learning and memory abilities of SHR rats with ADHD and thus control the core symptoms of ADHD, i.e., hyperactivity, impulsive behavior, and inattention. Baicalin exerts its effect in a dose-dependent manner, and high-dose baicalin has the most significant effect, but compared with MPH, it needs a longer time to play its therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28774371      PMCID: PMC7390057     

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  22 in total

1.  [Effect of baicalin on ATPase and LDH and its regulatory effect on the AC/cAMP/PKA signaling pathway in rats with attention deficit hyperactivity disorder].

Authors:  Rong-Yi Zhou; Jiao-Jiao Wang; Yue You; Ji-Chao Sun; Yu-Chen Song; Hai-Xia Yuan; Xin-Min Han
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-05

Review 2.  Does serotonin deficit mediate susceptibility to ADHD?

Authors:  Emili Banerjee; Krishnadas Nandagopal
Journal:  Neurochem Int       Date:  2015-02-12       Impact factor: 3.921

Review 3.  Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.

Authors:  Rae Thomas; Sharon Sanders; Jenny Doust; Elaine Beller; Paul Glasziou
Journal:  Pediatrics       Date:  2015-03-02       Impact factor: 7.124

4.  The anticonvulsant and neuroprotective effects of baicalin on pilocarpine-induced epileptic model in rats.

Authors:  Yang-Feng Liu; Fei Gao; Xiao-Wei Li; Rui-Hua Jia; Xian-Dong Meng; Rui Zhao; Yun-Yun Jing; Ying Wang; Wen Jiang
Journal:  Neurochem Res       Date:  2012-04-17       Impact factor: 3.996

Review 5.  Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.

Authors:  James M Swanson; Marcel Kinsbourne; Joel Nigg; Bruce Lanphear; Gerry A Stefanatos; Nora Volkow; Eric Taylor; B J Casey; F Xavier Castellanos; Pathik D Wadhwa
Journal:  Neuropsychol Rev       Date:  2007-03       Impact factor: 7.444

6.  Homer expression in the hippocampus of an animal model of attention-deficit/hyperactivity disorder.

Authors:  Qin Hong; Yan-Ping Wang; Min Zhang; Xiao-Qin Pan; Mei Guo; Fei Li; Mei-Ling Tong; Rong-Hua Chen; Xi-Rong Guo; Xia Chi
Journal:  Mol Med Rep       Date:  2011-04-26       Impact factor: 2.952

7.  Baicalin may have a therapeutic effect in attention deficit hyperactivity disorder.

Authors:  Rongyi Zhou; Xinmin Han; Jiaojiao Wang; Jichao Sun
Journal:  Med Hypotheses       Date:  2016-10-23       Impact factor: 1.538

8.  Baicalin improved the spatial learning ability of global ischemia/reperfusion rats by reducing hippocampal apoptosis.

Authors:  Oumei Cheng; Zhenhua Li; Yu Han; Qingsong Jiang; Yong Yan; Ke Cheng
Journal:  Brain Res       Date:  2012-07-11       Impact factor: 3.252

9.  Effects of methylphenidate on attentional set-shifting in a genetic model of attention-deficit/hyperactivity disorder.

Authors:  Ai-hua Cao; Lin Yu; Yu-wei Wang; Jun-mei Wang; Le-jin Yang; Ge-Fei Lei
Journal:  Behav Brain Funct       Date:  2012-02-28       Impact factor: 3.759

Review 10.  Logical fallacies in animal model research.

Authors:  Espen A Sjoberg
Journal:  Behav Brain Funct       Date:  2017-02-15       Impact factor: 3.759

View more
  2 in total

1.  Effects of prenatal exposure to temephos on behavior and social interaction.

Authors:  Ana Olívia Martins Laurentino; Fabiana Durante de Medeiros; Juliana de Oliveira; Naiana da Rosa; Tamires Mateus Gomes; Eduardo de Medeiros Peretti; Josiane Somariva Prophiro; Jucélia J Fortunato
Journal:  Neuropsychiatr Dis Treat       Date:  2019-03-11       Impact factor: 2.570

Review 2.  Neuroprotective Effects of Quercetin in Pediatric Neurological Diseases.

Authors:  Lourdes Alvarez-Arellano; Marcela Salazar-García; Juan Carlos Corona
Journal:  Molecules       Date:  2020-11-28       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.